🇺🇸 FDA
Patent

US 9284276

N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof

granted A61KA61K31/4704A61K9/20

Quick answer

US patent 9284276 (N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/4704, A61K9/20, A61K9/2813, A61K9/48